Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc. > If you want to stick with the sector
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(143)
•••
Comment by ilvmyt5son Dec 07, 2020 1:24pm
115 Views
Post# 32050329

RE:RE:RE:If you want to stick with the sector

RE:RE:RE:If you want to stick with the sector WEED needs to catch up to APHA. It's not the charts. They probably will do a raise after their U.S. edibles product line expansion announcement which will make APHA more attractive.  

ilvmyt5s wrote: I don't really understand why you have to pay a $25 premium for WEED over APHA

Share Price $9.60 $35.27 3.67
  APHA WEED APHA:WEED
Total Revenue $542.34 $398.77  
Gross Profit $190.98 -$31.68  
Net Income -$84.63 -$1,321.33  
EPS -$0.33 -$3.80  
ebitda $2.93 -$1,377.33  





LeJames wrote: Knowing Irwin, I would be really surprised if he didn't take advantage of this rally and do an offering. The current set-up would be ideal in that an offering at this price won't upset too many shareholders while a discount can still attract lots of institutions. As for the chart, I guess you guys who think the charts are "identical" don't like the doji? Cheers.  


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities